8-bromo cyclic adenosine monophosphate and Neuroectodermal Tumors, Primitive, Peripheral

8-bromo cyclic adenosine monophosphate has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, TP; Mania-Farnell, BL; Merrill, BJ; Yamamura, HI1
Davis, TP; Konings, PN; Mania-Farnell, BL; Merrill, BJ1

Other Studies

2 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Neuroectodermal Tumors, Primitive, Peripheral

ArticleYear
Second messenger activators regulate CCK mRNA in the human neuroepithelioma cell line SK-N-MCIXC.
    Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Cholecystokinin; Exons; Gene Expression; Humans; Neuroectodermal Tumors, Primitive, Peripheral; Restriction Mapping; RNA, Messenger; Second Messenger Systems; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1994
Regulation of CCK mRNA in the human neuroepithelioma cell line SK-N-MCIXC in response to second messenger activators.
    FEBS letters, 1993, Nov-29, Volume: 335, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Cholecystokinin; Cyclic AMP; Dimethyl Sulfoxide; Gene Expression Regulation; Humans; Kinetics; Neuroectodermal Tumors, Primitive, Peripheral; Protein Kinase C; RNA, Messenger; Second Messenger Systems; Tetradecanoylphorbol Acetate

1993